Chemicals and Drugs

Cyclin-Dependent Kinase Inhibitor p19

An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

6 entry terms
  • CDKN2D Protein
  • Cyclin-Dependent Kinase Inhibitor 2D
  • INK4D Protein
  • p19INK4D Protein
  • Cyclin Dependent Kinase Inhibitor 2D
  • Cyclin Dependent Kinase Inhibitor p19

MeSH Record

Aspects Covered

30 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2006(1995)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Cyclin-Dependent Kinase Inhibitor p19. Medical Subject Headings (MeSH). 2026. Unique ID D050764. http://id.nlm.nih.gov/mesh/2026/D050764
  2. Cyclin-Dependent Kinase Inhibitor p19. In: Wikidata. https://www.wikidata.org/wiki/Q21105502